This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Hydrocodone NT

Pfizer Inc.

Drug Names(s): Hydrocodone-naltrexone, ALO-04, ALO 04

Description: Hydrocodone NT is a formulation of long-acting hydrocodone in combination with naltrexone, an opioid antagonist. Hydrocodone NT is specifically designed to resist certain common methods of misuse and abuse associated with long-acting hydrocodone products that are currently available.

Deal Structure: Alpharma was acquired by King Pharmaceuticals on December 30, 2008.

In October 2010, Pfizer and King Pharmaceuticals announced that they have entered into a definitive merger agreement. In February 2011, Pfizer completed its acquisition of King.


Hydrocodone NT News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug